Presentation TCT 2012 Overview 1: Biological Therapies for Heart Failure: Clinical Perspectives and Progress Presenter: Timothy Henry October 23, 2012
Presentation TCT 2012 TCT-40. Incidence and Acute Clinical Outcomes of Small Side Branch Occlusion After Implantation of Everolimus-eluting Bioresorbable Vascular Scaffold in the ABSORB-EXTEND... Presenter: Takashi Muramatsu October 23, 2012
Presentation TCT 2012 TCT-91. Peri-valvular Aortic Regurgitation in Balloon-expendable and Self-expendable TAVI procedures: Predictors and Impact on Clinical Outcome - Insights from the FRANCE2 Registry Presenter: Eric van Belle October 23, 2012
Presentation TCT 2012 TCT-27. Transformation from a Predominant Transfemoral to Transradial Access Site for Percutaneous Coronary Intervention (PCI): Insights into an Achievable Revolution within... Presenter: Richard Anderson October 23, 2012
Presentation TCT 2012 TCT-1. Risk Factors for Cerebral Embolization After Carotid Artery Stenting with Embolic Protection – A DW–MRI Study in 827 Patients Presenter: Klaudija Bijuklic October 23, 2012
Presentation TCT 2012 What Will We Learn from the EXCEL Trial that We Do Not Already Know? Presenter: Gregg Stone October 23, 2012
Presentation TCT 2012 TCT-14. Effects of Renal Sympathetic Denervation on Heart Rate and Atrioventricular Conduction in Patients with Resistant Hypertension Presenter: Christian Ukena October 23, 2012
Presentation TCT 2012 Atrial Fibrillation: 1. CHADS2 vs. CHA2DS2-VASc Risk Assessment. 2. AHA/ACC vs. ACCP/ESC Approach to Stroke Prevention. Presenter: Peter Brady October 23, 2012
Presentation TCT 2012 Case 3: During an Iliofemoral Intervention Presenter: D. Christopher Metzger October 23, 2012